NOV - 8 2004 K 0454
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS
SYNERON MEDICAL Ltd. POLARIS DS / Comet
This summary of safety and effectiveness information is being submitted in
accordance with the requirements of the SMDA 1990 and 21 CFR 807.92.
Submitter: Syneron Medical Ltd., Sultam Industrial park, P.O.B. 550,
Yokneam Elite 20692, Israel.
Tel. +972-4-909-7424 ext. 7604, Fax +972-4-909-7417
Name of the Device: Polaris DS / Comet
Predicate Devices: The Polaris DS /Comet is substantially equivalent to a
combination of four laser powered surgical instruments (21
CFR 878.4810, procode GEX): Polaris DS, manufactured by
Syneron Medical Ltd. and subject of K024064. Polaris WR,
manufactured by Syneron Medical Ltd. and subject of
K031671. LightSheer, manufactured by Lumenis Inc. and
subject of K003614. Mythos 500, manufactured by Msq Ltd.
and subject of K030805
Device Description: The Polaris DS / Comet is a device indicated for hair removal,
permanent hair reduction. The Polaris DS is intended for use on
all skin types, (Fitzpatrick skin type I-VI), including tanned
skin. The Polaris DS / Comet treatment is based on the
principle of selective (electromagnetic) thermolysis. According
to this principle, parameters of optical and RF energy
(spectrum, exposure duration and energy density) are chosen
and optimized to selectively damage to the hair follicle without
damaging the surrounding tissues.
The Polaris DS is intended for use in dermatology for hair removal, permanent hair
reduction. The Polaris DS is intended for use on all skin types, (Fitzpatrick skin type
L-VD), including tanned skin.
Based upon an analysis of the overall performance characteristic for the device,
Syneron Medical Ltd. believes that no significant differences present. Therefore the
Polaris DS / Comet should raise no new issues of safety or effectiveness.
\A Y \ 1 Yeo Nae Kt = ee iy \ < we \
Date Dr. Amir Waldman,
Director regulatory affairs
Syneron medical Ltd.

7?
f DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
“om Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
NOV - 8 2004
Dr. Amir Waldman
Director, Regulatory Affairs
Syneron Medical Ltd.
Sultam Industrial Park
P.O.B 550 Yokneam Elite
20692, Israel
Re: K041959
Trade/Device Name: Polaris DS / Comet
Regulation Number: 21 CFR 878.4810, 21 CFR 878.4400
Regulation Name: Laser surgical instrument for use in general and plastic surgery and in
dermatology, Electrosurgical cutting and coagulation device and
accessories
Regulatory Class: If
Product Code: GEX, GE]
Dated: October 21, 2004
Received: October 25, 2004
Dear Dr. Waldman:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
: general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class If] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21

Page 2 - Dr. Amir Waldman
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification: The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Thiam C. Varveot
Celia M. Witten, Ph.D., M.D.

Director

Division of General, Restorative

and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure

510(k) Number (if known) K 0 4 | q 5 ] .
Device Name Polaris DS / Comet.
Indications For Use:
The Polaris DS / Comet is indicated for hair removal, permanent hair
reduction. The Polaris DS / Comet is intended for use on all skin types,
(Fitzpatrick skin type I-VI), including tanned skin.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED]
ee
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use Va OR Over The Counter Use
(Per 21 CFR 801.109)
: (Optional Format 1-2-96)
(Division Sign-Off)
Division of General, Re-* «i
and Neurological Device.
510(k) Number_40.4/95-7

